Moolec Science SA (MLEC)
1.68
-0.19
(-10.16%)
USD |
NASDAQ |
Oct 16, 16:00
1.57
-0.11
(-6.55%)
After-Hours: 20:00
Moolec Science Shareholders Equity (Quarterly)
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2024 | 2.797M |
| September 30, 2024 | 5.693M |
| June 30, 2024 | 6.816M |
| March 31, 2024 | 6.639M |
| December 31, 2023 | 6.684M |
| September 30, 2023 | 8.892M |
| June 30, 2023 | 10.11M |
| March 31, 2023 | 11.59M |
| December 31, 2022 |
| Date | Value |
|---|---|
| September 30, 2022 | 23.89M |
| June 30, 2022 | 135.00M |
| March 31, 2022 | 135.08M |
| December 31, 2021 | 134.86M |
| September 30, 2021 | 134.95M |
| June 30, 2021 | 134.08M |
| March 31, 2021 | 135.95M |
| December 31, 2020 | 0.0124M |
| September 30, 2020 | 0.0132M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arcadia Biosciences, Inc. | 0.633M |
| Zivo Bioscience, Inc. | -3.382M |
| PMGC Holdings, Inc. | 16.74M |
| TFA Therapeutics, Inc. | -- |
| Archer-Daniels-Midland Co. | 23.57B |